Virtus ETF Advisers LLC
- SEC CIK
- 0001587281
- Latest filing
- Aug 11, 2026
LXRX holding history
Lexicon Pharmaceuticals, Inc. in every 13F filed by Virtus ETF Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −425,269−100.0% | Sold out | Holders |
| Q4 2024 | 425,269 | $314.1K | 0.1% | +245,297+136.3% | Added | Holders |
| Q3 2024 | 179,972 | $282.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 179,972 | $302.4K | 0.1% | −113,120−38.6% | Reduced | Holders |
| Q1 2024 | 293,092 | $703.4K | 0.4% | +42,169+16.8% | Added | Holders |
| Q4 2023 | 250,923 | $383.9K | 0.2% | +129,212+106.2% | Added | Holders |
| Q3 2023 | 121,711 | $132.7K | 0.1% | −15,739−11.5% | Reduced | Holders |
| Q2 2023 | 137,450 | $314.8K | 0.2% | +137,450 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −39,262−100.0% | Sold out | Holders |
| Q1 2022 | 39,262 | $82.0K | <0.1% | −2,322−5.6% | Reduced | Holders |
| Q4 2021 | 41,584 | $164.0K | 0.1% | −2,794−6.3% | Reduced | Holders |
| Q3 2021 | 44,378 | $213.0K | 0.1% | −2,321−5.0% | Reduced | Holders |
| Q2 2021 | 46,699 | $214.0K | 0.1% | +46,699 | New | Holders |